Transpulmonary thermodilution provides a viable alternative to echocardiography and pulmonary artery catheters for continuous bedside monitoring of left ventricular systolic function in critically ill patients.
Answers are grounded in this paper and cite their sources.
Transpulmonary thermodilution indices may aid bedside LV systolic monitoring; leaves open prospective validation versus echocardiography or catheters before adoption.
Evaluating the systolic function of the left ventricle (LV) is important in the hemodynamic management of the critically ill patients with circulatory failure. Echocardiography is considered the standard monitor for estimating the LV function at the bedside in the intensive care unit. However, it requires a trained operator and is not a real-time monitoring tool. For monitoring of the systolic function, the pulmonary artery catheter has been the gold standard for a long time. However, now there are alternatives to this device, with transpulmonary thermodilution being one of them. This paper provides an overview of the usefulness of the transpulmonary thermodilution-derived indices for assessing systolic function at the bedside.
No takes yet. Share an insight, caveat, or question.
Aguilar et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: